RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections

Infection with the SARS-CoV2 virus can vary from asymptomatic, or flu-like with moderate disease, up to critically severe. Severe disease, termed COVID-19, involves acute respiratory deterioration that is frequently fatal. To understand the highly variable presentation, and identify biomarkers for d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wargodsky, Richard, Dela Cruz, Philip, LaFleur, John, Yamane, David, Kim, Justin Sungmin, Benjenk, Ivy, Heinz, Eric, Irondi, Obinna Ome, Farrar, Katherine, Toma, Ian, Jordan, Tristan, Goldman, Jennifer, McCaffrey, Timothy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791486/
https://www.ncbi.nlm.nih.gov/pubmed/35081105
http://dx.doi.org/10.1371/journal.pone.0261679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791486/
https://www.ncbi.nlm.nih.gov/pubmed/35081105
http://dx.doi.org/10.1371/journal.pone.0261679

Ejemplares similares